The effect of atorvastatin on biochemical and hemostatic profile of patients with polycystic ovary syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201208299626N1

Enrollment

Registered

2012-08-29

Start date

2012-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS. Polycystic ovarian syndrome

Interventions

Intervention 1: Atrovastatin in case group. Intervention 2: OCP in control group.

Treatment - Drugs

Atrovastatin in case group

OCP in control group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteriion: all patients with PCOS. Exclusion criteria: any disease in recent month; ingestion of any drug that might affect insulin level, lipids and ovary function in recent 6 months; previous statin use; any chanfe in lifestyle during study; pregnancy and lactation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Biochemical and Hemostatic profile. Timepoint: Three month. Method of measurement: Paraclinical.	—

Secondary

Measure	Time frame
Alternation in biochemical and hemostatic profile. Timepoint: Three month. Method of measurement: Paraclinical.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Majid Mobaseri

Tabriz University of Medical Sciences

mobasserimajid@yahoo.com+98 41 1335 7850

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026